Tag: medicare
Impact report finds no major change in balance between CAS and...
An evaluation of trends in the utilisation of carotid artery stenting (CAS) versus carotid endarterectomy (CEA) has found there to be “no major change”...
R3 Vascular secures WCG IRB approval and CMS category B Medicare...
R3 Vascular today announced that it has received WCG Institutional Review Board (IRB) approval for the ELITE-BTK pivotal trial of its Magnitude drug-eluting next-generation...
New CMS reimbursement code “severely underpays” for drug-coated balloons
Drug-coated balloon (DCB) angioplasty devices have been categorised by the US Centers for Medicare and Medicaid Services (CMS) into the same billing code as...
